I'm sure many holders share your sentiment.
When you bring a guy like John Michailidis he's going to want to review every nut and bolt.
He's the former Australia and New Zealand CEO of Teva Pharmaceuticals with over 10 drug discovery commercialisation successes and product launches in various jurisdictions over his career.
My guess is he's getting his fingerprints on everything, I remain bullish.
- Forums
- ASX - By Stock
- IHL
- Share your ideas and thoughts.
Share your ideas and thoughts., page-223
-
- There are more pages in this discussion • 468 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)